• P-ISSN 0974-6846 E-ISSN 0974-5645

Indian Journal of Science and Technology


Indian Journal of Science and Technology

Year: 2023, Volume: 16, Issue: 11, Pages: 823-828

Original Article

A Dosimetric Study on the Impact of Collimator Angles in Nasopharynx Carcinoma using VMAT Planning

Received Date:27 September 2022, Accepted Date:26 February 2023, Published Date:20 March 2023


Objective: This study aims to rule out the best collimator angle using Monte- Carlo algorithm in Nasopharynx Carcinoma (NPC) with adequate tumour coverage and less OAR. Methods: Twenty-nine NPC patients were selected retrospectively. VMAT with dual arc were made with same constraints but with different collimator angles for each patient. Total often plans were created for each patient with a collimator angles of 0;5;10;15;20;25;30;35;40;45 in Monaco Treatment Planning System(TPS) using Monte-Carlo algorithm. Plans were evaluated based on Dosimetric parameters such as target coverage, organ at risk (OAR), conformity index(CI) and homogeneity index(HI). Mean dose (Dmean), and Maximum dose (Dmax) of OARs were also analysed. Data were further evaluated by using SPSS software. Findings: The VMAT plans with collimator angles 15◦-30◦ demonstrated better target coverage with a range of (92-94) %0.7195 for the high-dose PTV and significant reduction in monitor units (MU) by an average of 75 with a CI (0.95-0.96)0.0068. Moreover, significant reduction in Dmax of Brainstem and Right optic nerve were obtained with increasing angles. Also,5◦-10◦ showed least PTV coverage and 45◦ got highest MUs compared to 0◦. Novelty : This study shows that collimator angles 15◦-30◦ is superior compared with other angles in Ca Nasopharynx VMAT planning by Elekta-HD Versa Linac using Monte-Carlo algorithm.

Keywords: Ca Nasopharynx; Collimator angle; Montecarlo algorithm; Elekta HD Versa Linac; VMAT


  1. Wang R, Kang M. Guidelines for radiotherapy of nasopharyngeal carcinoma. Precision Radiation Oncology. 2021;5(3):122–159. Available from: https://doi.org/10.1002/pro6.1123
  2. Bertholet J, Mackeprang PHH, Mueller S, Guyer G, Loebner HA, Wyss Y, et al. Organ-at-risk sparing with dynamic trajectory radiotherapy for head and neck cancer: comparison with volumetric arc therapy on a publicly available library of cases. Radiation Oncology. 2022;17(1):122. Available from: https://doi.org/10.1186/s13014-022-02092-5
  3. Home. Available from: http://www.aapm.org/
  4. Franzese C, Fogliata A, Loi M, Badalamenti M, Franceschini D, Comito T, et al. Dosimetric impact of volumetric modulated arc therapy for nasopharyngeal cancer treatment. Reports of Practical Oncology and Radiotherapy. 26(1):101–110. Available from: https://doi.org/10.5603/RPOR.a2021.0017
  5. Kim YH, Park D, Park HR, Kim WT, Kim DH, Bae JS, et al. Effect of collimator angles on the dosimetric results of volumetric modulated arc therapy planning for patients with a locally-advanced nasopharyngeal carcinoma. Journal of the Korean Physical Society. 2017;70(5):539–544. Available from: https://doi.org/10.3938/jkps.70.539
  6. Dimitri FY, Manulang F, Nelly, Wahyono Y, Susworo R, Pawiro SA. Organ at risk dose verification in nasopharyngeal cancer VMAT planning with collimator comparison between single arc and double arc. IOP Conference Series: Materials Science and Engineering. 2018;432:012024. Available from: https://doi.org/10.1088/1757-899X/432/1/012024
  7. Jihong C, Kaiqiang C, Yitao D, Xiuchun Z, Yanyu C, Penggang B. Evaluation of auto-planning in VMAT for locally advanced nasopharyngeal carcinoma. Scientific Reports. 2022;12(1):4167. Available from: https://doi.org/10.1038/s41598-022-07519-3
  8. Ishikura S, Ishikawa K, Murakami N, Kodaira T, Yoshinori K, Tsuchiya Y, et al. Masahiro Inada, Yasumasa Nishimura. Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1). 2022;17:133. Available from: https://doi.org/10.1186/s13014-022-02105-3
  9. Niu X, Xue F, Liu P, Hu C, He X. Long-term outcomes of nasopharyngeal carcinoma patients with T1-2 stage in intensity-modulated radiotherapy era. International Journal of Medical Sciences. 2022;19(2):267–273. Available from: https://doi.org/10.7150/ijms.68394


© 2023 Thomas et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Published By Indian Society for Education and Environment (iSee)


Subscribe now for latest articles and news.